New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Evolus, Inc.
EOLS
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

741M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 May 2025

741M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 May 2025

11.65USD

Shape0.10 ( 0.87%)
Market Closed (as of Apr 25, 20:00 EDT)
favorite-chart

Relative Strenght

81
favorite-chart

Volume Buzz

-6%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

35%

Quote Panel

Shape
Updated April 28, 2025
1W 11.38 % 1M -3.16 % 3M -19.99 % 1Y -0.51 %

Key Metrics

Shape
  • Market Cap

    740.79M


  • Shares Outstanding

    63.59M


  • Share in Float

    56.11M


  • Dividende

    0


  • Earning Date

    07 May 2025


  • Price Target

    11.65


  • Average Volume

    849645


  • Beta

    0.971


  • Range

    8.67-17.82


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.evolus.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.78x

P/S Ratio

130.25x

P/B Ratio

23.5

Debt/Equity

-18.9%

Net Margin

$-0.8

EPS

How EOLS compares to sector?

P/E Ratio

Relative Strength

Shape

EOLS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.17
vs -0.27

Q2.23

arrow
arrow

N/A

-0.22
vs -0.38

Q3.23

arrow
arrow

N/A

-0.19
vs -0.32

Q4.23

arrow
arrow

N/A

-0.14
vs -0.16

Q1.24

arrow
arrow

N/A

-0.13
vs -0.17

Q2.24

arrow
arrow

N/A

-0.07
vs -0.22

Q3.24

arrow
arrow

N/A

-0.19
vs -0.19

Q4.24

arrow
arrow

+107%

0.01
vs -0.14

Q1.25

arrow
arrow

N/A

-0.14
vs -0.13

Q2.25

arrow
arrow

N/A

-0.12
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+23%

41.7M  vs 33.9M

Q2.23

arrow
arrow

+33%

49.3M  vs 37.2M

Q3.23

arrow
arrow

+46%

49.3M  vs 33.9M

Q4.23

arrow
arrow

+40%

61M  vs 43.6M

Q1.24

arrow
arrow

+42%

59.3M  vs 41.7M

Q2.24

arrow
arrow

+36%

66.9M  vs 49.3M

Q3.24

arrow
arrow

+24%

61.1M  vs 49.3M

Q4.24

arrow
arrow

+29%

78.9M  vs 61M

Q1.25

arrow
arrow

+22%

72.4M  vs 59.3M

Q2.25

arrow
arrow

+23%

82.3M  vs 66.9M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-213%

-2.13
vs -0.71

Q2.23

arrow
arrow

+261%

2.61
vs -2.13

Q3.23

arrow
arrow

+87%

0.87
vs 2.61

Q4.23

arrow
arrow

+57%

0.57
vs 0.87

Q1.24

arrow
arrow

-71%

-0.71
vs 0.57

Q2.24

arrow
arrow

-59%

-0.59
vs -0.71

Q3.24

arrow
arrow

-325%

-3.25
vs -0.59

Q4.24

arrow
arrow

-123%

-1.23
vs -3.25

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

129

129
vs 121

7%

Q2.23

arrow
arrow

141

141
vs 129

9%

Q3.23

arrow
arrow

144

144
vs 141

2%

Q4.23

arrow
arrow

156

156
vs 144

8%

Q1.24

arrow
arrow

172

172
vs 156

10%

Q2.24

arrow
arrow

163

163
vs 172

-5%

Q3.24

arrow
arrow

169

169
vs 163

4%

Q4.24

arrow
arrow

167

167
vs 169

-1%

Earnings Growth

Latest News